Hope for a new treatment for the autoimmune neuromuscular disease Myasthenia Gravis (MG)

by 3P Biopharmaceuticals

3P Biopharmaceu​ticals, a leading Contract Development and Manufacturing Organization (CDMO) specialized in process development and cGMP manufacturing of biologics, together with Toleranzia, a Swedi...

Read more

3P Biopharmaceuticals asiste a las ferias más relevantes del sector en formato online

by 3P Biopharmaceuticals

3P Biopharmaceuticals, compañía biotecnológica CDMO especializada en el desarrollo de procesos y fabricación bajo normas de correcta fabricación (cGMPs) de medicamentos biológicos y productos de...

Read more

3P Biopharmaceuticals and Viscofan go ahead with this innovative project of regenerative medicine for cardiac use

by 3P Biopharmaceuticals

3P Biopharmaceuticals, a leading Contract Development and Manufacturing Organization (CDMO) specialized in process development and cGMP manufacturing of biologics, and Viscofan BioEngineering, the Bus...

Read more

A new anti-tumour treatment is one step closer to the clinic thanks to a new collaboration between In3Bio and 3P Biopharmaceuticals

by 3P Biopharmaceuticals

3P Biopharmaceuticals, a leading Contract Development and Manufacturing Organization (CDMO) specialized in process development and cGMP manufacturing of biologics, has been chosen by In3Bio, the UK ba...

Read more

3P Biopharmaceuticals inicia colaboración con la compañía americana Zhittya para el tratamiento del Parkinson

by 3P Biopharmaceuticals

3P Biopharmaceuticals (3P), compañía biotecnológica CDMO especializada en el desarrollo de procesos y fabricación bajo Normas de Correcta Fabricación (cGMPs) de medicamentos biológicos y prod...

Read more

3P Biopharmaceuticals incorpora a Keensight Capital como accionista mayoritario

by 3P Biopharmaceuticals

3P Biopharmaceuticals (3P), compañía especializada en el desarrollo de procesos y fabricación GMP de productos biológicos (CDMO) anuncia la incorporación de Keensight Capital, una de las principa...

Read more

3P Biopharmaceuticals firma un acuerdo de fabricación con la empresa sueca Affibody para el tratamiento de la psoriasis

by 3P Biopharmaceuticals

El acuerdo cubre la transferencia y el desarrollo de proceso, así como la fabricación GMP del medicamento candidato de Affibody

Read more

3P Biopharmaceuticals e Intervacc afianzan su colaboración con la fabricación a gran escala de Strangvac®

by 3P Biopharmaceuticals

3P Biopharmaceuticals y la compañía sueca Intervacc, confirman la producción a gran escala de Strangvac®, la vacuna contra las paperas equinas en la que llevan tiempo colaborando.

Read more

3P Biopharmaceuticals enters into a new manufacturing agreement with the Dutch Biotech Company Xenikos

by 3P Biopharmaceuticals

3P Biopharmaceuticals, a leading CDMO specialized in the process development and GMP manufacturing of biologics, has signed a collaboration agreement with the Dutch biotech company Xenikos B. V. (Xeni...

Read more

3P Biopharmaceuticals successfully completes the expansion and improvement of its facilities

by 3P Biopharmaceuticals

3P Biopharmaceuticals has successfully completed the project for the expansion and improvement of its facilities in Noáin (Spain) that had been carried out over the past months. The investment exceed...

Read more

How to select the perfect partner, next CPhI 2015 by 3PBiopharmaceuticals, Charles River, Covance and Menarini Biotech

by 3P Biopharmaceuticals

"The challenge of Partner selection: the best travel companion in biologics drug development adventure” will discover the keys to success in this major challenge

Read more
Subscribe to Directory
Write an Article

Recent News

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Palobiofarma announces the completion th...

by Palobiofarma

Palobiofarma S.L. is pleased to announce the “last patient last visi...

Photos Stream